上海普佑生物医药

Puyou Biotech is a Shanghai-based biotechnology company dedicated to the discovery and development of innovative protein degradation therapies. The company focuses on molecular glue degraders and PROTAC (Proteolysis-Targeting Chimera) technologies to address undruggable targets in oncology and immunology. By leveraging its proprietary discovery platform, Puyou Biotech aims to develop highly selective small molecule drugs that induce the degradation of pathogenic proteins. The leadership team consists of experienced scientists from top-tier global pharmaceutical companies, positioning the firm at the forefront of the protein degradation field in China. The company has successfully secured significant early-stage funding from prominent venture capital firms to advance its internal pipeline.